JUPITER NEUROSCIENCES, INC. JUNS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2024-12-03
JUPITER NEUROSCIENCES, INC. statistics & valuation
Market cap$13.5M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Gross margin | 80.6% | — | — |
| Operating margin | -40873.2% | — | — |
| Net margin | -39662.8% | — | — |
| Return on assets | -155.4% | -39.3% | -3219.3% |
| Return on equity | 471.9% | -58.5% | 82.5% |
| Current ratio | 0.65 | 2.31 | 0.00 |
Source: SEC EDGAR filings · CIK 0001679628 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.